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Abstract
Background: Molecular chaperones help to restore the native states of proteins after their
destabilization by external stress. It has been proposed that another function of chaperones is to
maintain the activity of proteins destabilized by mutation, weakening the selection against
suboptimal protein variants. This would allow for the accumulation of genetic variation which could
then be exposed during environmental perturbation and facilitate rapid adaptation.
Results: We focus on studies describing interactions of chaperones with mutated polypeptides.
There are some examples that chaperones can alleviate the deleterious effects of mutations
through increased assistance of destabilized proteins. These experiments are restricted to bacteria
and typically involve overexpression of chaperones. In eukaryotes, it was found that the
malfunctioning of chaperones aggravated phenotypic aberrations associated with mutations. This
effect could not be linked to chaperone-mediated stabilization of mutated proteins. More likely, the
insufficient activity of chaperones inflicted a deregulation of multiple cellular systems, including
those responsible for signaling and therefore important in development. As to why the assistance
of mutated proteins by chaperones seems difficult to demonstrate, we note that chaperone-
assisted folding can often co-exist with chaperone-assisted degradation. There is growing evidence
that some chaperones, including those dependent on Hsp90, can detect potentially functional but
excessively unstable proteins and direct them towards degradation instead of folding. This implies
that at least some mutations are exposed rather than masked by the activity of molecular
chaperones.
Conclusion: It is at present impossible to determine whether molecular chaperones are mostly
helpers or examiners of mutated proteins because experiments showing either of these roles are
very few. Depending on whether assistance or disposal prevails, molecular chaperones could speed
up or slow down evolution of protein sequences. Similar uncertainties arise when the concept of
chaperones (mostly Hsp90) as general regulators of evolvability is considered. If the two roles of
chaperones are antagonistic, then any (even small) modification of the chaperone activities to save
mutated polypeptides could lead to increased misfolding and aggregation of other proteins. This
would be a permanent burden, different from the stochastic cost arising from indiscriminate
buffering of random mutations of which many are maladaptive.
Reviewers: This article was reviewed by A. S. Kondrashov, J. Höhfeld (nominated by A. Eyre-
Walker) and D. A. Drummond (nominated by C. Adami). For the full reviews, please go to the
Reviewers' comments section.
Published: 26 February 2008
Biology Direct 2008, 3:5 doi:10.1186/1745-6150-3-5
Received: 6 February 2008
Accepted: 26 February 2008
This article is available from: http://www.biology-direct.com/content/3/1/5
© 2008 Tomala and Korona; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
Page 2 of 16
(page number not for citation purposes)
Background
The phenotype often remains stable in spite of extensive
variation in the genetic material [1,2]. This has been dem-
onstrated in experiments in which many genes were
deleted [3-6] or mutated [7,8]. It has been proposed that
such genetic robustness may be an adaptation because it
reduces phenotypic penetration of deleterious mutations
[9,10]. This concept is still under debate and its full com-
prehension will require detailed study of the underlying
mechanisms [11]. It has been suggested that molecular
chaperoning may be one of these mechamisms [12].
Chaperoning is carried out by molecules originally
denoted as heat shock proteins (Hsps). They are especially
abundant in cells subject to environmental stress in which
they help to reactivate destabilized and/or aggregated pro-
teins [13-16]. Most chaperones are also present in nor-
mally growing cells [17,18]. Under these conditions,
random misfolding is especially likely to affect proteins
that mutated in such a way as to reduce their structural sta-
bility. Regardless of whether the source of damage is envi-
ronmental or mutational, its effect on a protein is similar.
Hydrophobic regions of a polypeptide, normally buried
inside the protein, become exposed on its surface. This is
a signal of protein damage, recognized universally by a
variety of molecular chaperones [19,20]. Through binding
and release of the destabilized proteins, the chaperones
perform a dual action: they ameliorate the danger that
proteins will aggregate via the hydrophobic patches and
promote the refolding of proteins to their native structures
[21-24]. It seems straightforward to assume that because
the protein signal and the chaperone reaction are univer-
sal, the overall effect of chaperoning is also universal. That
is, since the chaperones are known to maintain activity of
proteins affected by stress, they should also support func-
tioning of proteins destabilized by mutation. The notion
that molecular chaperones are potent and general agents
of genetic robustness has gained wide recognition [11]. Its
experimental corroboration has been sought in studies
involving both bacteria [25-27] and eukaryotes [12,28].
In general, these experiments show that abnormal pheno-
types become more evident when cellular levels of chap-
erones decline. However, such results only hint at the
possibility that the observed phenotypic changes result
from the poor performance of mutated proteins when the
required (re)folding activity of chaperones is insufficient
[12,25-28]. An alternative explanation is that malfunc-
tioning of the molecular chaperones leads to malfunc-
tioning of many non-mutated proteins [29]. As it is
explained later in more detail, the inflicted epistatic effects
can match or even exceed those associated with the muta-
tions destabilizing proteins. Therefore, it is necessary to
discriminate carefully between these two different aspects
of chaperone activity.
A reevaluation of the role of chaperones in evolution
appears unavoidable in light of key developments in
research on molecular and cellular functions of these pro-
teins. Over the two last decades, they were found to par-
ticipate in a wide spectrum of cellular processes.
Molecular chaperones are known to assist folding of both
nascent and nearly mature proteins, as well as protein
translocation, remodeling, secretion, and degradation
[30]. Although chaperones engaged in these processes are
diverse and often non-homologous, they all recognize
their protein substrates in a generally similar way, i.e. by
direct binding to hydrophobic surfaces. However, under
normal cellular metabolism the binding of a destabilized
protein by a chaperone is often only the first step in its fur-
ther processing. The polypeptide can then be released and
allowed to continue its folding. However, the chaperones
may also stop or revert folding of a protein to enable its
translocation or modification [30]. A particularly intrigu-
ing possibility is that some of the most abundant chaper-
ones recognize excessively unstable proteins and direct
them towards degradation [31,32]. Originally discovered
as agents devised specifically to rescue misfolded proteins,
chaperones were then found to participate actively in
quality control and disposal of troubled chains in order to
prevent toxic interactions among themselves and with
other cellular elements. In this perspective, the chaper-
ones are helpers at the time of stress, but can become
examiners at the time of normal metabolism, While this is
not new for molecular biologists (recently reviewed in
[33-36]), it has not been considered in relation to pheno-
typic masking and genetic robustness [12,28,29,37].
Central to this article will be the question of how the activ-
ity of chaperones affects the strength of purifying selec-
tion. We accept the opinion that molecular chaperones
have a generally stabilizing effect on genetic networks and
that mutations are more likely buffered when the net-
works are robust. Our focus will be on direct interactions
between the chaperones and mutated proteins. In particu-
lar, we ask when and how the action of molecular chaper-
ones can be diverted from rescue to disposal of
destabilized proteins and whether this may influence the
rate and mode of protein evolution.
Molecular chaperones and phenotypic buffering 
in bacteria
Thermally induced instability is only one possible cause
of protein misfolding. Others include overcrowding, tran-
scriptional and translational errors, absence of necessary
post-translational partners for proteins, and different
chemical and physical stresses. Overcrowding seems to be
especially important and universal because the density of
macromolecules (proteins and RNAs) within cells is very
high, typically about 300 g/l [38]. These conditions neces-
sarily promote frequent misfolding and aggregation ofBiology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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polypeptides [39], especially in regions of intense transla-
tion because elongating chains remain largely unfolded
until synthesis of a whole protein domain is finished [40].
Translational errors represent another important factor
promoting misfolding because they are inherent to bio-
synthesis and occur at a considerably high rate, between
1/1,000 and 1/10,000 per codon, which may lead to
improper amino acids sequences in up to 20% of
polypeptides [41]. Bacteria have evolved a chaperone sys-
tem that assists folding of nascent proteins. Its three major
constituents iclude TF, DnaK, and GroEL (Fig. 1A). TF is
bound to the ribosome and provides initial shielding to
an elongating polypeptide [42]. DnaK is a typical Hsp70
chaperone that recognizes short stretches of hydrophobic
amino acids which are expected to occur at multiple posi-
tions of most proteins [19]. Individually acting molecules
of DnaK bind and release polypeptides in a cycle governed
by its two cofactors, DnaJ and GrpE [43]. This helps to
unwind and separate intertangled molecules and in this
way facilitates proper folding. The Hsp60 type chaperone
GroEL works in a different way. It oligomerizes into hep-
tamers forming ring-shaped cages with hydrophobic api-
cal regions. These recognize the hydrophobic parts of
substrates which are then, with the help of a smaller chap-
erone partner GroES, translocated to the interior where
their folding can be completed without danger of interfer-
ence by other proteins [20]. DnaK and GroEL bind not
only the nascent proteins but also those secondarily mis-
folded and aggregated, both under normal metabolism
and stress [44-46], (Fig. 1B). They are always abundant
and taken together form the core of the bacterial chaper-
one machinery [24]. The bacterial cell also hosts other
chaperones but these two are most likely to be involved in
phenotypic buffering of genetic variation.
Elevated levels of the GroEL type chaperone are found in
the endosymbiotic bacteria Buchnera. It has been sug-
gested that this is an adaptation to a high incidence of
mutational destabilization of proteins in these bacteria.
They live inside cells in small populations, making natural
selection inefficient in removing slightly deleterious
mutations from protein coding genes [25]. To test this
hypothesis, laboratory populations of E. coli with experi-
mentally accumulated multiple deleterious mutations
were used. It was found that the mutated clones grow bet-
ter under induced overexpression of the chaperones
GroEL or DnaK [26]. In another experiment involving E.
coli, mutations were gradually accumulated. Clones that
(A) Chaperone assisted folding of nascent and newly synthesized proteins in bacteria [34] Figure 1
(A) Chaperone assisted folding of nascent and newly synthesized proteins in bacteria [34]. An elongating polypep-
tide is initially shielded by TF (trigger factor), a chaperone attached near the exit of the ribosomal tunnel. DnaJ (bacterial 
Hsp40) initiates binding of the polypeptide by DnaK (Hsp70) during translation. The initial, co-translational assistance of these 
chaperones is sufficient for the folding of many proteins (upper path). Other proteins are chaperoned by DnaK also after they 
detach from the ribosome (middle path). There are also proteins whose post-translational folding is assisted by DnaK and then 
by the GroEL/ES system. (B) Chaperone assisted reactivation of secondarily misfolded bacterial proteins. An unfolded protein 
can be rescued or directed to proteolysis. Participation of the molecular chaperones in recruiting single chains from aggrega-
tion and then in their correct folding is well documented. Possible cooperation of the chaperones with proteases has also been 
reported (see the text for more details). In bacteria, folding of both the primarily and secondarily unfolded proteins is assisted 
by the same chaperones.Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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survived had enhanced levels of DnaK and GroEL [27].
The latter finding is especially interesting, because it sug-
gests that an increase in mutational load selects for a con-
current increase in the cellular level of chaperones.
However, among the tens or even hundreds of mutations
involved in this and the two former studies, there must be
some that reduced the level of expression and not the
structural stability of proteins. Lowered levels of these
proteins could create rate limiting steps in cellular metab-
olism. Assuming that some of these proteins require chap-
erones for maturation or remodeling [47,48], increased
levels of the chaperones would probably be advanta-
geous. Hypothetically, this, and not the need to support
structurally destabilized proteins, could be the reason why
natural selection favors high levels of chaperones.
Another interesting result was obtained in a study in
which an induced overexpression of GroEL resulted in
suppression of single heat-sensitive mutations, but not
cold-sensitive or temperature insensitive ones [49].
Because heat sensitivity typically accompanies protein
instability, this result is close to demonstrating that chap-
erones can restore the functionality of mutationally desta-
bilized proteins and thus provide means for phenotypic
masking in its clearest form. Still better evidence for this
comes from experiments with temperature sensitive
mutants of the coat protein of the phage P22. Mutated
protein is unstable and tends to misfold and aggregate. It
was explicitly shown that GroEL/S interacted in vivo with
the mutated proteins significantly more intensely than
with wild-type protein. Normal levels of the chaperone
were sufficient to save most of the mutated protein from
aggregation at low temperatures. At standard and higher
temperatures, aggregation was curbed by artificial overex-
pression of the chaperone [50]. This example shows that
there are proteins which become dependent on molecular
chaperones after mutation and suggests that bacterial cells
may increase their buffering capabilities by increasing the
cellular level of molecular chaperones. At this point, it is
appropriate to ask how the upregulation of chaperones
may affect the functioning of other, non-mutated ele-
ments of cellular metabolism.
Molecular chaperones are often viewed as competitors to
proteases as both of these classes of enzymes recognize
destabilized proteins. Normally more abundant, the
chaperones are likely to bind transiently most structurally
defective proteins and promote their folding, thereby pre-
venting degradation [51]. Interactions with the chaper-
ones would be important for the mutated proteins,
especially if they extend over multiple rounds of binding
and release, because this could salvage them from pro-
teases. However, even if activity of bacterial chaperones
strictly opposes that of proteases, it is still possible that
under normal growth the quality control system is bal-
anced at a level of sensitivity appropriate for folding of
wild-type but not mutated proteins. Indeed, at least some
mutationally destabilized proteins are rapidly degraded
under normal cellular concentration of DnaK [52]; recall
that stabilization of mutated proteins was observed when
chaperones were overexpressed [49]. Moreover, there is
evidence that a bacterial chaperone (DnaJ) can aid bacte-
rial proteases (Lon and ClpAP) in the degradation of a
mutationally destabilized protein and that this support is
not restricted to maintaining the protein in a soluble state
[53] but is likely to take more active forms [54]. Similarly,
there is indication that if GroEL fails to catalyze the proper
folding of a protein, it can facilitate its rapid degradation
[55]. Overexpression of molecular chaperones is likely to
interfere with protein degradation. Moreover, overex-
pressed chaperones change the range of proteins with
which they interact [56]. Thus, it is likely that permanent
change in the cellular level of chaperones may result in
negative fitness effects, especially in nature with its exten-
sive environmental fluctuations. On the other hand, it
must be remembered that even significant reduction [50]
or extreme increase [26] in the level of crucial bacterial
chaperones, such as GroEL/S, leave the cells viable under
the laboratory conditions.
In conclusion, both the genetic data and molecular mod-
els suggest that chaperone-mediated masking of protein
structural instability in bacteria is possible. However, the
activity of molecular chaperones appears fine tuned to
avoid interference with the protein quality control and
multiple other processes. It is not yet possible to estimate
how frequently the chaperone-mediated phenotypic
masking actually works. However, it appears legitimate to
postulate that in bacteria molecular chaperones may occa-
sionally facilitate fixation of a partially deleterious muta-
tion by alleviating its negative phenotypic effects. This
may involve transient or sustained increase in the cellular
level of chaperones, but the associated costs need not be a
long term evolutionary handicap if populations are effec-
tively small, making selection relatively inefficient.
Molecular chaperones and phenotypic buffering 
in eukaryotes
The problem of molecular overcrowding is no less acute in
eukaryotes. Eukaryotic chaperones are to a large extent
homologous to those known in bacteria, although they
are more numerous, diverse, and specialized. In particu-
lar, they probably constitute two major networks, one
active at the time of stress, and the other associated with
the production and maturation of new proteins. Accord-
ingly, expression of the former is correlated with reaction
to stress and that of the latter with the intensity of transla-
tion [57]. This article focuses on the network associated
with protein synthesis because these chaperones work
throughout most of the lifetime of eukaryotes and there-
fore are more relevant to phenotypic masking of muta-Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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tions. As in bacteria, there are cytosolic Hsp70 chaperones
that bind elongating polypeptides already during transla-
tion. After their synthesis is complete, some proteins are
released by the chaperones and ready to function. Others
remain bound to the Hsp70 molecules which direct them
to more specialized folding machines, e.g. TRiC (a ring-
shaped octamer, homologous to bacterial GroEL) or
Hsp90. It appears that the folding of a nascent protein is
continuously escorted by molecular chaperones, begin-
ning with the moment when its N-terminus leaves the
ribosome's tunnel and ending when its final or nearly
final three-dimensional structure is formed [18]. Indeed,
most destabilized proteins must be sequestered by the
molecular chaperones because there are relatively few
unfolded or partially unfolded polypeptides in the cytosol
[58]. Consistent with this, it has been found that at most
a few percent of polypeptides are degraded shortly after
synthesis, suggesting that most are protected from proteo-
lytic enzymes [59]. Thus, at least in the eukaryotic cell, the
newly synthesized and secondarily destabilized proteins
do not form a sizable pool of free molecules that is con-
stantly bound and released by the chaperones. Rather,
they are passed along defined pathways of assisted folding
[18]. The question is whether the chaperones participat-
ing in these pathways work to bring a mutated protein to
a structure that is functionally active even if its stability is
reduced.
The folding of proteins in the eukaryotic cell can be
divided into an early phase, common to and similar for
many proteins, and a late phase, constrained to special
types of proteins (Fig. 2A). The early phase starts during
translation when the Hsp70 chaperones bind an elongat-
ing polypeptide chain. This phase is functionally sepa-
rated from other chaperone activities because it is initiated
by specialized Hsp40 chaperones that are bound to ribos-
omes and direct Hsp70 molecules to a nascent protein
[60]. In yeast, both the co-translationally acting Hsp40
and Hsp70 are distinct from other proteins of these types
present in the cell [61,62]. Deletion of genes coding for
these proteins does not affect the yeast cell's viability. This
raises the question of what is the phenotypic expression of
mutations when the co-translational system of chaper-
ones is or is not active. This question is especially impor-
tant because the chaperones participating in translation
are likely to bind many if not all newly synthesized pro-
teins [57]. To answer this, an array of thermally sensitive
(protein destabilizing) mutations in different genes was
tested. The expectation that the phenotypic effects of pro-
tein malfunctioning will be more severe in the chaperone-
deficient cells was not confirmed [63]. This result falsifies
the hypothesis of chaperone-mediated masking of muta-
tional effects in its strongest form, stating that virtually all
chaperones able to bind unwound proteins will in effect
support their proper folding [64].
The phenotypic masking of mutations was extensively
studied in late-folding chaperones. In eukaryotes, some
proteins, including those participating in cellular signal-
ing and regulation, require the assistance of the Hsp90
chaperone in order to finish their folding and to attain a
functionally active structure (Fig. 2B) [65]. Hsp90 can be
partially inactivated by geldamycin. In fruit flies and
plants, such treatment results in phenotypic differentia-
tion of individuals whose parents, although phenotypi-
cally alike, are genetically different. The new phenotypic
variants can be fixed in selection experiments. Some do
not need further pharmacological stimulation to endure
[12,28]. In this way, the basic assumptions of evolution-
arily relevant phenotypic masking have gained support.
First, genetic variation can be covered up under a com-
mon phenotype through the activity of the Hsp90 chaper-
one. Second, the variation can escape the masking effect
of the chaperone (in natural environments this may be
accomplished by stress) and serve as raw material for her-
itable adaptation. These findings, comprehensive at the
level of genetic analysis, have not been further supported
by deciphering the underlying molecular mechanisms
[29,37,64,66]. It is also worth noting that some other
experiments with fruit flies have shown that the buffering
effect of Hsp90 is neither as universal nor as strong as orig-
inally believed [67,68]. To further discuss this issue, it is
necessary to introduce the concept of protein quality con-
trol in eukaryotic cells.
Chaperones in eukaryotic protein quality 
control
The native structure of a protein is only one of a great
number of conformations that can be adopted by a
polypeptide extending over hundreds of amino acids.
Non-native spatial structures of non-mutated polypep-
tides generally occur in two situations, during and shortly
after synthesis, and after the destabilization of a mature
protein. Protein structural stability may also be altered
because of errors arising at transcription or translation.
Damaged proteins are marked for disposal by ubiquityla-
tion and then degraded by proteasomes [69]. The accuracy
of the cellular systems recognizing incorrect structures and
their ability to discriminate between transiently misfolded
wild type chains and those permanently changed by
mutation are still insufficiently known. Of special interest
is the proposition that the molecular chaperones can
cooperate actively with the ubiquitin/proteasome system
in selecting structurally unstable proteins for degradation
[31,32]. If true, this would mean that eukaryotic chaper-
ones do not invariably support the functioning of the
defective proteins, including those mutated.
A well studied example of cooperation between molecular
chaperones and a protein degradation system is the qual-
ity control of proteins in endoplasmatic reticulum (ER).Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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Apart from chaperones specialized in the control of the
ER-specific protein modifications, there exists a chaper-
one system attending the primary control of general sta-
bility. In mammals, it is based on BiP, a member of the
Hsp70 family. This protein binds nascent and newly syn-
thesized proteins after their co-translational translocation
through the ER membrane and assists folding in the
lumen. BiP recognizes a variety of proteins and apparently
interacts most intensely with slow or atypical folders [70].
Correctly folded proteins proceed to further modifica-
tions and export, defective ones are retained in the ER and
then are unfolded and ubiquitylated while being translo-
cated through the membrane on their way to cytosolic
proteasomes [30,71,72]. It has been shown for a series of
thermally sensitive mutants of ER proteins that the inten-
sity of their eradication increases with greater instability of
the mutants [73,74]. Thus, these molecular chaperones
sense the folding problems, cannot overcome them, and
facilitate the degradation of the troubled proteins.
The Hsp70 chaperones serve as detectors of general fold-
ing problems also in the eukaryotic cytosol. Normal pro-
teins experience routine binding by the chaperones; in
such cases, a likely scenario is that co-chaperones called
'nucleotide exchange factors' will help to release timely
the protein from the chaperones [43,75,76]. Proteins that
exhibit substantial structural instability are likely passed
from the chaperones to proteases. For example, a mutated
form of CFTR (cystic fibrosis transmembrane conductance
regulator) shows prolonged interaction with the cytosolic
Hsp70 system which probably constitutes a signal for its
ubiquitylation and degradation [77,78]. Covalent attach-
Chaperone-assisted folding of proteins in eukaryotes [34] Figure 2
Chaperone-assisted folding of proteins in eukaryotes [34].(A) Early phase of folding of newly synthesized proteins. 
Hsp40 molecules attached to ribosomes (rHsp40) activate cytosolic Hsp70 molecules and direct them to elongating polypep-
tides. This co-translational chaperoning may be sufficient for the correct folding of many proteins. Folding of some others is 
assisted by Hsp70 also post-translationally. This can require collaboration of Hsp70 (or prefoldin, not shown) with TRiC. 
Finally, Hsp70 can direct some proteins to Hsp90, which initiates the late phase of folding. (B) Late phase of protein folding and 
protein quality control in eukaryotes. A protein held by Hsp70 can be released and free from further assistance of the chaper-
ones providing that it manages to adopt a proper conformation. In case of excessively unstable proteins, Hsp70 can recruit the 
co-chaperones CHIP and BAG1 and this eventually leads to protein degradation in the proteasome. Some special proteins are 
transferred from Hsp70 to Hsp90 with the help of the co-chaperone HOP. Successfully transferred protein is held by Hsp90 
which enables its final modification; alternatively, the protein is directed to proteolysis. The binding by Hsp70 is typical both for 
newly synthesized and secondarily misfolded polypeptides. If the latter happens, the binding of Hsp70 to polypeptides is gov-
erned by Hsp40 chaperones other than those attached to ribosomes. This is one way to differentiate the specificity and inten-
sity of the eukaryotic chaperone activity between normal metabolism (protein synthesis) and stress reaction (protein 
reactivation).Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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ment of ubiquitins is performed by ubiquitin-conjugating
enzymes, E2, and ubiquitin ligases, E3 [69]. E3 ligases are
especially important for protein quality control because
they are responsible for selection of polypeptides destined
for ubiquitylation. It has been shown that one of such
ligases, CHIP, is effectively a co-chaperone of Hsp70. It
docks to the Hsp70 chaperone that holds a misfolded pro-
tein, recruits an E2 enzyme and triggers the ubiquitylation
of the protein. Two further steps are performed by a single
protein, BAG-1, another co-chaperone of Hsp70. It links
the chaperone to a proteasome and releases the ubiqit-
ylated polypeptide so it can be transferred from the former
to the latter [31,32]. The whole model is impressively
complete in its functional and structural aspects. Under-
standably, it serves as the chief example of cooperation,
instead of competition, between cytosolic chaperones and
proteases.
CHIP-mediated protein quality control and degradation
has been demonstrated for several different proteins [32].
Still, it is not clear whether most destabilized proteins are
detected and disposed in this way. Notably, there is no
known homologue of CHIP in the budding yeast which
therefore must apply a different interface between the
chaperones and the proteases. Recently, a new example of
a cytosolic chaperone-mediated system of decision mak-
ing concerning folding or degradation has been described.
The folding of a newly synthesized mammalian cytosolic
protein, VHL tumor suppressor, requires that Hsp70
cooperates with TRiC. When the folding is defective,
Hsp70 transfers the protein to a chaperone complex that
includes Hsp90 and this eventually leads to degradation
of VHL. The two pathways are distinct: TRiC is required
for folding but dispensable for degradation, the reverse is
true for Hsp90. Hsp70 is at the crossroads, its activity is
necessary for both functions [79]. This system, and that
dependent on CHIP, have much in common. Both
assume that a troubled protein is first recognized and
bound by the Hsp70 chaperone and that the outcome of
this event depends on subsequent interactions between
the protein, Hsp70, and other chaperones and co-chaper-
ones.
It is likely that other chaperone systems also participate in
the broadly defined quality control of proteins. It has
already been mentioned that an experimental attempt to
demonstrate that the yeast co-translational Hsp40/70 sys-
tem can support the functioning of mutationally destabi-
lized proteins was unsuccessful [63]. This result becomes
comprehensible when protein quality control is taken
into account. The Hsp70 chaperones are present on the
pathways leading either to protein folding or protein dis-
posal. Apparently, proteins that contain mutations caus-
ing defects large enough to produce thermo-sensitive
phenotypes are directed mostly to the second path (Fig.
3). Indeed, ongoing experiments show that the in vivo
activity of mutated proteins is actually less efficient when
the Hsp40/70 system is active. This suggests that the chap-
erones participate in sorting out the defective molecules
(Tomala and Korona, unpublished). It has been postu-
lated that the general purpose of co-translational chaper-
ones is to enhance the efficiency of protein folding [18].
However, it is also plausible that not low folding effi-
ciency but the danger of formation of toxic misfolded
and/or aggregated species is the ultimate reason why the
newly synthesized proteins are chaperoned [57,80]. In
both cases, but especially in the latter, the co-translational
chaperones would rather expose than conceal genetic
defects because their function would be to scrutinize the
folding of gene products which would result in preferen-
tial elimination of mutants.
The quality of proteins maturing in the ER is strictly con-
trolled both in terms of general stability and correctness of
specific modifications [72,81]. The hypothesis of pheno-
typic buffering of mutational damage by the molecular
chaperones has never been explicitly applied to these pro-
teins. Therefore ER proteins, comprising a large share of
all proteins present in the eukaryotic cell, will not be fur-
ther taken into account as potential subjects of the muta-
tion-masking activity of chaperones.
Direct and indirect effects of Hsp90 activity
Hsp90 is a chaperone engaged in late phases of protein
folding. Substrates of Hsp90 are already partly folded;
many of which are proteins awaiting final conformational
changes making them active as signal transducers [65].
The standard role of Hsp90 is to bind and maintain these
proteins in a conformation that enables the required
modification to be carried out [82]. At the time when the
concept of Hsp90-mediated masking was born, it could
be assumed that Hsp90 performs its function by direct
and recurrent binding and release of the assisted protein
and that such activity would be most desirable if the pro-
tein was mutated [12]. The current understanding of sub-
strate acquisition by Hsp90 is markedly different. A
typical protein requiring the assistance of Hsp90 is first
bound by Hsp70 and only then transferred from Hsp70 to
a Hsp90-centered complex [82,83]. There is no indication
that this pattern does not apply to proteins allegedly
engaged in phenotypic masking. Thus, Hsp90 client pro-
teins would not be exempt from the quality control typi-
cal for the substrates of Hsp70 (Fig. 3). Furthermore, it is
difficult to imagine that a protein affected by mutation is
chaperoned in a special way in the Hsp90 complex, if it
gets into it, to increase the chance for required modifica-
tion [35,83]. It was mentioned above that atypical sub-
strates of Hsp90 may be instead directed towards
degradation [79].Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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A revealing example of how Hsp90 actually aids protein
quality control has been reported recently. Hsp90 is
needed at a certain stage of maturation of CFTR. The fold-
ing of a mutant CFTR is often terminated by the quality
control process described above, mediated by Hsp70 and
CHIP. If the defective CFTR is nonetheless faced with
Hsp90, it is not yet safe. Hsp90 has a sequentially chang-
ing complement of co-chaperones. They determine the
scenario of folding and the structure/behavior of a protein
must conform to the expected pattern to allow efficient
co-operation. Some mutant CFTR fall outside the range of
tolerable incongruity and therefore the composition of
co-chaperones of Hsp90 shifts towards factors promoting
ubiquitylation and degradation [84]. It is possible that a
similar evaluation is carried out for different mutations in
different proteins and that at least some are subject to
chaperone-assisted degradation. This was demonstrated
for mutations with relatively strong destabilizing effects,
but there is no indication that less affected proteins are
not disposed in this way, although probably at a lower
rate. In sum, the general idea that Hsp90 ameliorates phe-
notypic expression of mutations by directly assisting the
folding of destabilized proteins becomes increasingly
incompatible with current molecular models (Fig. 3).
This conclusion is not contradicted by the experimental
findings that phenotypic differentiation of genetically var-
iable organisms increases when the activity of Hsp90
decreases. Hsp90 can have a few hundred client proteins
[65]. The hypothesis of phenotypic masking was origi-
nally focused on mutations residing in these proteins.
However, the direct clients of Hsp90 are critical for func-
tioning of many pathways in which an even larger
number of proteins are engaged. Malfunctioning of
Substrate selection and processing in the eukaryotic Hsp70/Hsp90 chaperone system Figure 3
Substrate selection and processing in the eukaryotic Hsp70/Hsp90 chaperone system. Newly synthesized or sec-
ondarily unfolded proteins are recognized and bound by Hsp70. These can be either proteins that require assistance of Hsp90 
at later steps of their folding or any other polypeptides. The latter (green line) can attain their native configuration with the 
assistance of the folding Hsp70 complex [18]. or be disposed with the help of the degrading Hsp70 complex if they are exces-
sively unstable [34]. It is also possible that proteins that normally do not need to interact with Hsp90 in the process of their 
folding are nevertheless passed to the degrading Hsp90 complex when they have to be disposed [79]. Proteins that do require 
Hsp90 for the late steps of their folding (red line) can be directed to degradation before contacting this chaperone if they are 
excessively unstable [31]. Otherwise, they are passed from Hsp70 to Hsp90 through an intermediate complex containing both 
these chaperones. Maturation of these proteins can be finished in the late folding Hsp90 complex [82] or aborted in the 
degrading Hsp90 complex if they do not follow expected scenario of folding [84]. Molecules which need to be assisted by 
Hsp90 but are dropped before their fold is completed have to re-enter their path of chaperone-assisted maturation primarily, 
or perhaps exclusively through binding to the Hsp70 molecules [83]. This renders them to another round of quality control.Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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Hsp90 will result in malfunctioning of its client proteins
even if the latter are not mutated. This, in turn, will jeop-
ardize functioning of multiple pathways, especially those
containing mutated and therefore less efficient proteins
[64]. In this way, the proper functioning of Hsp90, and
other chaperones, may buffer phenotypic expression of
mutations even if the chaperones do not physically inter-
act with the mutated proteins. "Mutated" need not mean
destroyed. Heritable variants of proteins whose function-
ing depends directly or indirectly on Hsp90 can give dif-
ferent phenotypic traits whenever the cellular level of this
chaperone falls below some critical threshold. In this way,
activity of Hsp90 buffers phenotypic expression of genetic
variation [29,66]. It has been claimed that the depend-
ence of phenotypic variation on the activity of Hsp90
makes this chaperone a very special capacitor of evolution
[28,37,66]. However, "release" of phenotypic variation in
response to malfunctioning of a gene is ubiquitous and
not restricted to Hsp90. For example, malfunctioning of
transcriptional factors also 'uncovers' genetic variation
because such defects are likely to lead to extensive and
genotype-dependent changes in expression of genes. Fur-
thermore, altered functioning of chromatin remodeling
enzymes may uncover not only genetic but also epigenetic
variation [85]. More generally, malfunctioning of any
gene interacting with many other genes is likely to
increase phenotypic variation [86].
Molecular chaperones are included among the mecha-
nisms promoting stabilization because they support mul-
tiple links among proteins and in this way add to the
overall robustness of genetic networks [87]. However, it is
purely speculative to propose that an important factor
governing the evolution of molecular chaperones is the
need to increase the capability of organisms for the rapid
remodeling of phenotypes at a time when evolutionary
novelties are needed. According to this view, Hsp90 could
be considered a regulator of evolvability because it can
modulate the expression of genetic variation and in this
way hide or expose mutations to natural selection [66,88].
It has been recognized that one evolutionary cost of this
mechanism is the potential accumulation and occasional
exposure of a number of mutations which would very
often be harmful rather than advantageous [e.g.
[37,66,88]]. However, any compromise in the accuracy of
protein quality control would bring another effect, that is,
impaired elimination of all damaged proteins, including
those produced by non-mutated genes. Overcrowding
and translational errors can-not be avoided. This cost
would not be stochastic and would not increase variation.
Instead, it would lower the fitness of all individuals in a
population and would not promote the origin of hopeful
variants. This is another reason for caution when suggest-
ing that molecular chaperones may serve as modulators of
evolvability. The sensitivity of organisms to impairment
of protein quality control, especially long-lived ones, is
increasingly well recognized in biomedicine.
Molecular chaperones and disease
The search for links between phenotypes and molecular
mechanisms is especially difficult if complex traits, such
as fitness or health, are considered. For example, it was
found that the overexpression of Hsp70 in fruit flies sup-
presses neurodegeneration caused either by proteins with
expanded polyglutamine tracts or mutated α-synuclein
[89,90]. In both cases the beneficial role of the Hsp70
chaperone probably does not result from the restoration
of the functional structures of the proteins but from a
reduction of cytotoxicity caused by protein aggregation.
On the one hand, this is an example of a phenotypic
cover-up mediated by molecular chaperones. On the
other, these phenotypically masked mutations probably
have little bearing on future adaptation. Other examples
come from studies on the role of Hsp90 in cancer devel-
opment. The pharmacological inhibition of this chaper-
one may lead to successful treatment [91]. Interpretation
of this finding is not straightforward. It has been hypoth-
esized that cancer cells harbor a large amount of mutated
proteins and therefore their functioning is dependent on
the ability of Hsp90 to buffer multiple genetic damage
[92]. However, the repression of Hsp90 means that not
only mutated oncogenic proteins but also a number of
non-mutated signal proteins are directed towards degra-
dation instead of maturation [93]. A further complication
is that the transformed cells are faced with a stressful
tumor microenvironment owing to hypoxia, nutrient dep-
rivation, and acidosis [94]. The most important effect of
the repression of Hsp90, whether it is the unmasking of
mutations, disturbance of stress response, or general
deregulation of cellular signaling, is too complex to pin-
point at present [95]. Again, the potential adaptive value
of mutations associated with cancer and possibly masked
by Hsp90 is at best doubtful. We suggest that the analysis
of the role of chaperones at the level of whole cells or
organisms is hardly possible considering the present state
of theory and technology. Careful examination of direct
interactions between molecular chaperones and their 'cli-
ents' is probably a more promising way to understand
how molecular chaperoning shapes the evolution of pro-
teins.
Chaperones and selection against mutations
Only a small fraction of single substitutions change the
final structure of a protein so extensively that it becomes
non-functional. Many more lead to protein variants
whose final structure is little changed but stability is vio-
lated [96-99]. The severity of observable phenotypic
effects can vary extensively. A mutation has to cause a rel-
atively strong, thermally dependent destabilization to
result in a good conditional (ts, thermally sensitive) phe-Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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notype of practical laboratory value [100]. The remaining
mutations may have smaller phenotypic effects but are
nevertheless susceptible to the purifying action of natural
selection. The strength of natural selection is of course
limited, i.e. the complete eradication of continuously aris-
ing spontaneous mutations is not expected [101]. By mag-
nifying the decrease in the cellular level of mutationally
destabilized proteins, the chaperones would make such
selection more effective. This would lead to a reduction of
genetic polymorphism in populations. Insufficient
genetic variation can limit the rate of adaptation at the
time of environmental change [102]. Referring to the rate
of molecular evolution, chaperones, at least in some cases,
may slow it down by augmenting the phenotypic effects of
amino acid substitutions and thus making more likely
that the mutations would rather be purged by selection
than fixed by drift. This perspective is clearly different
from that postulating that chaperones are capacitors of
evolution because they typically mask phenotypic expres-
sion of mutations and thus maintain a reservoir of varia-
tion needed for the creation of novelties [12,28,37,66,88].
At present, experimental evidence for the decrease of the
deleterious effects of mutations as a direct result of chap-
erone activity is restricted to bacteria under specific labo-
ratory arrangements [49,50]. Evidence for augmentation
of mutational harm by the direct activity of chaperones is
also restricted to a few experiments, although it is found
both in prokaryotes and eukaryotes. Any claims about the
domination of the former or the latter outcome would be
premature at present.
Conclusion
Current understanding of protein folding and quality con-
trol is admittedly unsatisfactory and based on a limited
number of examples. However, the perspective adopted
here is supported not only by the discussed cases, but
reflects a major conceptual shift in research on the cellular
role of molecular chaperones. It was first established that
the heat shock proteins are also active under normal
metabolism and that different classes of the hsps have
generally similar activity at the molecular level [103]. This
leads to a model in which a nascent or destabilized pro-
tein benefits from assistance of different chaperones, each
contributing more or less individually and additively to
the process of folding [104,105]. In this scenario, the
chaperones are mostly helpers. It was then gradually rec-
ognized that the chaperones function often, if not mostly,
in assemblies which have their own structure and dynam-
ics [18,30,32,57]. The assistance provided by these
ordered consortia of chaperones appears conditional,
because incompatibility with the prescribed folding pro-
grams can trigger redirection to degradation [72,84]. In
this way, the quality control of proteins, especially large
and complex proteins, may be extended over several steps
of folding and maturation. This means an additional and
possibly important role of the chaperones as examiners.
The number of chaperone-assisted folding pathways is
probably limited, with many proteins coming through
each of them. Participation in the same pathway means
sharing the same folding environment. Thus, broad
classes of proteins meet similar requirements and this can
shape their evolution. A possible future direction in
research is to identify particular constraints or relaxations
that are created by different groups of chaperones. This
would be a truly comprehensive approach to the study of
the evolutionary role of molecular chaperones.
Reviewers' comments
Reviewer's report 1
A. S. Kondrashov, University of Michigan
This is a comprehensive review of a very interesting sub-
ject. How chaperones affect evolution in general and
selection against deleterious mutations in particular? The
answer depends on what chaperones are doing molecu-
larly. Do they mostly help proteins to fold correctly, or do
they mostly cause degradation of proteins that have some
structural defects? The data are controversial and, as far as
I can judge, the review comprehensively covers this field.
Because the paper mostly deals with molecular mecha-
nisms, and I am an evolutionary biologist, I really have
only two comments.
(1) Within the traditional paradigm of chaperones as
"helpers", there still is a radical difference between chap-
erones ameliorating impacts of deleterious mutations and
chaperones as capacitors of further evolution. Natural
selection can easily explain the first situation, but not the
second one. Indeed, an allele that increases fitness of indi-
viduals that carry a particular set of deleterious mutations,
because the affected proteins fold better, will be selected
for. In contrast, it is not clear how selection can favor an
allele that increases the potential of the population for
evolution in the future. Apparently, the only way this can
happen is through group selection, which is unlikely to
play any major role in nature.
Of course, one can argue that ameliorating impacts of del-
eterious mutations will inevitably lead to increase of the
standing genetic variance and to more opportunities for
evolution on the future. The first of these statements is cer-
tainly true, but the second may be wrong. The key issue is:
how often a mutation that is currently deleterious may
become advantageous in not-too-distant future? In other
words, are deleterious mutations deleterious uncondi-
tionally or many of them are conditionally beneficial?
Conventional wisdom of genetics seems to favor the first
possibility, although there may be exceptions. However,
this issue, which is central for our understanding of evolu-
tion, is still far from being settled.Biology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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(2) If, in contrast, chaperones mostly work as "protein
quality control", the reason for their evolution must be
removal of accidentally misfolded proteins and, perhaps,
proteins misfolded due to somatic mutations. In both
cases, the action of chaperones must increase fitness of a
particular genotype. Indeed, it is hard to imagine how
selection can favor an allele that make selection against
germline mutations more stringet, by reducing fitnesses of
a mutation-carrying genotypes.
Reviewer's report 2
J. Höehfeld, University of Bonn, Germany (nominated by
A. Eyre-Walker, University of Sussex, Brighton, UK)
In their manuscript Tomala and Korona propose a signif-
icant extension of previous concepts regarding the role of
molecular chaperones in evolution. Chaperones are cur-
rently widely viewed as capacitors of protein evolution
because their intrinsic activity as facilitators of protein
folding seems to enable them to maintain the function of
mutationally destabilized proteins and, therefore, pro-
vides a means to mask or buffer the phenotypic expression
of mutations. Tomala and Korona now argue for a re-eval-
uation of these functional concepts in particular in the
light of recent findings that point to an active involvement
of molecular chaperones in protein degradation. The find-
ings suggest that chaperoning of a mutationally destabi-
lized protein may not necessarily lead to the adoption of
a functional protein structure but may result in the
removal of the damaged protein by degradation as part of
the cellular protein quality control. Tomala and Korona
summarize in a comprehensive manner recent biochemi-
cal and cell biological findings regarding the cooperation
of chaperones with protein degradation systems and then
discuss the relevance of these findings with regard to the
proposed role of chaperones in evolution. As such the
manuscript represents a very interesting and stimulating
contribution to this area of research and should be
appealing to a broad range of researchers.
However, some aspects need further clarification. The
authors very strongly argue against previous functional
concepts not only on the basis of the recent findings
regarding chaperone/proteasome cooperation, but also
often point to mechanisms that would not involve direct
interactions between chaperones and mutationally desta-
bilized proteins. The authors mention, for example, that a
multitude of signaling pathways is dependent on the
activity of the chaperone Hsp90 and accordingly pharma-
cological inhibition of Hsp90 may result in a pleiotropic
disturbance of cell functions, resulting in the phenotypic
unmasking of mutations without involving a direct inter-
action with the mutated proteins. Importantly, this would
argue similarly against a role of the chaperones as folding
factors, rescuing the mutated proteins, and against a role
as facilitators of protein degradation, removing the pro-
tein garbage, as the molecular basis for phenotypic buffer-
ing. Therefore, it seems that the manuscript should be
restructured to separate these two aspects more clearly
(direct interactions involving either folding or degrada-
tion versus indirect effects).
If the authors consider chaperone-assisted degradation as
an important aspect also chaperone-assisted folding and
rescuing should be of relevance, because we know very lit-
tle about the mechanisms that determine the eventual
outcome of the chaperone/substrate interaction – being it
degradation or folding. In this regard the assessment of
previous work pointing to the role of chaperones as capac-
itors of protein evolution seems to be overly negative.
What is required is probably not a complete reconsidera-
tion of underlying molecular mechanisms but rather an
extension of previous concepts, which incorporates chap-
erone-assisted degradation. Chaperone-assisted degrada-
tion of a mutationally destabilized protein could
apparently prevent phenotypic expression because loss of
protein function often occurs without consequences for
viability. Mutations could accumulate on the level of the
DNA and could be unmasked when chaperone activity
declines for example under conditions of environmental
stress. This would further emphasize the role of chaper-
ones as capacitors of protein evolution – not invoking
solely a function as folding helpers – but considering a
broader role as protein examiners.
Minor issues
Paragraph 'Phenotypic masking revisited': The sentence
'the yeast co-translational Hsp40/70 system does not sup-
port functioning of mutationally destabilized proteins'
seems to be rather bold. Do the available experimental
data really justify this conclusion?
Regarding the increased sensitivity of cancer cells against
Hsp90 inhibitors the authors state that it is not clear, why
the scarcity of Hsp90 is more damaging to cancer cells that
to their non-transformed counterparts. It has been
observed, however, that Hsp90 in cancer cells displays a
higher affinity for inhibitory drugs, resulting in the
described differences in sensitivity
Authors' response
In line with the reviewer's suggestions we now separate more
clearly the direct effects of chaperone activity (stability of pro-
teins) from indirect ones (stability of genetic networks). This
distinction is mentioned in the abstract and then discussed in a
special chapter on direct and indirect effects of Hsp90 activity.
Indeed, the malfunctioning of multiple metabolic pathways
whose members depend on Hsp90 is likely to be detrimental for
many cellular processes and protein degradation is not an
exception. This is what we describe it as an extensive andBiology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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largely deleterious pleiotropy. We propose, however, that a
spontaneous change or experimental adjustment of chaperone
activity aimed at saving rare mutants would likely result in
decreased quality control of non-mutated proteins and the ensu-
ing danger of protein misfolding and aggregation. The costs can
be potentially high, especially for long-lived organisms. This is
why we hesitate to accept the concept of Hsp90 as a capacitor
of evolution.
While writing about 'reconsideration' we meant broadening,
not abandonment of previous concepts. This should be even
more clear now after introducing a new example of chaperone-
mediated alleviation of deleterious mutational effect (ts muta-
tion of a phage coat protein – suggested by Dr Drummond). We
now explicitly write that a few (one or two) but genuine exam-
ples of alleviation of mutational damage through intensified
interaction with chaperones can be found. Admittedly, exam-
ples of chaperone-mediated disposal of mutated proteins are
also scarce. Therefore in both the former and the present man-
uscript we do not try to answer the question whether chaperones
participate mostly in rescue or in destruction of mutated pro-
teins. Our intention was not to "strongly argue against previous
functional concepts". We did concentrate mostly on the involve-
ment of chaperones in protein quality control but this was
because this topic was insufficiently covered in the past. We do
not mean the specialist literature on chaperones and proteolysis
but journals on evolutionary biology.
The suggestions expressed in 'minor issues' have been accepted.
Reviewer's report 3
D. A. Drummond, FAS Center for Systems Biology, Har-
vard University (nominated by C. Adami, California Insti-
tute o Technology, Pasadena)
The central thesis of this work is that phenotypic masking
of mutations by chaperones has no direct empirical sup-
port when the evidence is carefully reviewed. Results from
the Teschke lab directly contradict this position as
described below. Taking the abstract at face value, the
authors' program comes across as largely an attempt to
discredit phenotypic buffering, which is unfortunate as
they provide a valuable review of chaperone systems in
the course of the paper. The work is elegantly written and
polished, and should simply be refocused as a review
which places phenotypic buffering in perspective rather
than attempting to dismiss it.
In my reading of the literature, both supporters and
detractors of the phenotypic buffering hypothesis accept
that chaperones have a wide variety of roles, and support-
ers do not claim that phenotypic buffering is the primary
activity of any chaperone. The strong argument the
present authors seem to dislike is the claim that all chap-
erones can rescue mutation-destabilized proteins to some
degree. They make an excellent case for many distinguish-
able roles for chaperones which cannot be reduced to
such a single common denominator, and as an answer to
this "strong buffering principle" the present work is wel-
come. Nevertheless, I do not think the strong principle is
widely credited.
The weak version holds that chaperones sometimes act to
rescue mutated proteins. Against this weaker argument
the authors's case is not particularly compelling. Consider
the circumstantial evidence. The authors admit through-
out the manuscript how plausible it would be for chaper-
ones to rescue mutated proteins; it is difficult to disagree.
Nonetheless, faced with the finding that mutated E. coli
lines grow better when chaperones are abundant, and that
other mutated lines have concomitantly increased chaper-
one levels, the authors argue ("Molecular chaperones and
phenotypic buffering in bacteria" section, paragraph 2)
that some mutations must have lowered the expression
levels of proteins resulting in rate-limiting metabolic
throttles, and some of these proteins must require chaper-
ones for maturation or remodeling. While this scenario is
possible, I do not find it convincing at all. "Expression-
decreasing mutations yielding rate-limiting abundance
changes in proteins that require chaperoning for matura-
tion or remodeling" seems a much more restrictive (read:
improbable) set than "destabilizing mutations in coding
sequences."
More convincingly to the authors, Van Dyk et al. Nature
(1989) reports that many ts alleles in S. typhimurium are
suppressed by overexpression of GroEL/S (not GroEL
alone as Tomala & Korona report). The present manu-
script admits, "Because heat sensitivity typically accompa-
nies protein instability, this result is probably the closest
to demonstrating that chaperones can restore the func-
tionality of mutationally destabilized proteins."
A better example comes from Nakonechny and Teschke
(JBC 1998) who show that, in vivo, 1) ts mutants of phage
coat protein are rescued by GroEL/S overexpression; 2)
wild-type GroEL/S supports plating efficiency (phage titer,
a measure of phage fitness) substantially better than
mutated versions of GroEL/S even at permissive tempera-
tures; and 3) GroEL binds directly to the destabilized coat
proteins more than wild-type coat proteins as assessed by
co-IP, increasingly so as a function of temperature.
Teschke's group has also carried out elaborate experi-
ments which establish that these ts mutants are indeed
destabilized (S.M. Doyle et al. JBC 2004).
The Teschke-group results represent a clear, complete
story of mutant instability, chaperone rescue by direct
interaction, and phenotypic buffering that has a direct
impact on fitness (in this case, of the phage). This storyBiology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
Page 13 of 16
(page number not for citation purposes)
directly contradicts the thesis of the present review. As a
case in point, these results answer the concerns used to
close the relevant paragraph: "Either phenotypic observa-
tions are convincing but molecular interpretation unsure,
or molecular mechanisms are nearly pinpointed but their
fitness effects unknown." I recommend that sentence be
removed and the Teschke results reported; as stated above,
the central thesis of the paper should be modified.
The related statement that chaperone overexpression may
impose fitness costs ("this study did not test for possible
negative fitness effects associated with the upregulated
expression of chaperones") comes across as sleight-of-
hand – the question is first whether chaperones can buffer
mutations, and only then if they can do so without harm-
ing the organism in other ways. The phenotypic buffering
hypothesis covers cases in which chaperones buffer a
mutation in an essential gene without being upregulated.
Perhaps the authors would argue that this is impossible,
but it is not obviously so (consider a mutation in an essen-
tial, low-expression protein which, in the absence of chap-
erones, would lead to kinetic trapping during folding, but
which is relieved in the presence of wild-type levels of
chaperones). As long as chaperones can render neutral
such mutations which are otherwise deleterious, those
mutations will go to fixation with a probability deter-
mined by population size instead of by their deleterious
effect, and the chaperone will have effectively buffered the
mutation in a way that contributes to evolutionary varia-
tion.
The authors' point that phenotypic buffering by Hsp90
has yet to be directly established is well-taken. Fixation on
Hsp90 proceeds from the original Rutherford and
Lindquist paper, but it must be emphasized that the
importance of that paper derived largely from the obser-
vation of morphological variants in the absence of chap-
erone – contrast this with loss of function in the Teschke
coat-protein mutants. (One may rightly ask whether the
morphological variants found have any evolutionary sig-
nificance, or are just the organismal equivalent of mis-
folding.) If the authors wish to focus on Hsp90 studies,
they have a case; still, the possibility of phenotypic buffer-
ing by any chaperone seems to be the broader and more
important question.
The authors improperly overlook the role of translation
errors as by far the dominant source of mutated, destabi-
lized proteins in the cell and therefore a major relevant
substrate of chaperones. Translational missense errors
occur at a rate between 1e-3 and 1e-4 per codon (Ogle and
Ramakrishnan Ann Rev Biochem 2005), so that roughly
20% of molecules of an average-length (~400-residue)
protein are expected to contain at least one missense error.
For long proteins such as dynein or titin, it is likely that
most protein molecules contain at least one error.
Mutated proteins in the cell must therefore expected to be
common under normal physiological conditions. It seems
plausible that many chaperones exist, in part, to rescue
these non-heritable mutants from the premature aggrega-
tion and kinetic traps to which they are prone, so that they
may go on to be productive members of cellular society.
In this view, phenotypic buffering is simply an inevitable
side-effect – chaperones, after all, cannot tell which
mutant proteins arose because of a DNA mutation or a
translation error. An argument that chaperones exist *in
order to* buffer genetic variation cannot be supported by
this model, but I am unaware of such claims.
At any rate, I suggest that the present authors devote more
time to discussing translation errors, perhaps using C.M.
Grant et al. Mol Micro 1989 as jumping-off point, where
it is shown that elevated mistranslation induced by paro-
momycin induces the heat-shock response in yeast.
As suggested above, the authors may wish to consider
refocusing their review. My reading of the authors' evi-
dence and the literature yields a rather more accommo-
dating view than the present manuscript espouses. In
short, the optimal strategy for the cell is to save (buffer)
proteins which can be saved, and degrade those which
cannot. Consider only thermodynamic stability as a nar-
row example. No amount of chaperoning can rescue a
thermodynamically unstable protein. But because muta-
tions induce a wide range of free energy changes, some
mutations will terminally destabilize a protein (so that it
must be disposed of), some will marginally destabilize it
(so that it needs chaperone help to avoid aggregation or
degradation during folding, but no more), and some will
leave its stability unchanged or even stabilize it (no wor-
ries!). An elaborate, connected system of chaperones must
triage these patients, with the outcome optimally depend-
ing on the severity of the wound. Different chaperones
may play different roles, but it must be beneficial to save
some patients. (The authors emphasize that the reason to
dispose of a protein may be to prevent formation of a
toxic misfolded species rather than preserve a functioning
protein, an argument I find very convincing and one that
equally supports assisting the folding of some otherwise
wobbly molecules.) The major questions concern how,
and how well, this blind, stochastic triage system catego-
rizes its substrates, which chaperones play which (pre-
sumably overlapping) roles, and how the system can be
recoverably or irretrievably perturbed.
Authors' response
We never claimed that genuine buffering through direct contact
between mutated proteins and chaperones is impossible. Since
the reviewer cites several of our sentences, we would also like to
cite one: "In conclusion, both the genetic data and molecularBiology Direct 2008, 3:5 http://www.biology-direct.com/content/3/1/5
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models suggest that chaperone-mediated masking of protein
structural instability in bacteria is possible." The reviewer con-
centrates on our evaluation of experiments with bacteria. First,
we uphold our opinion that experiments involving a large
number of unknown mutations are difficult to interpret. In such
situations, low levels of chaperones may mean insufficient
chaperoning of many unstable proteins. Alternatively, a syn-
thetically harmful effect may be produced through genetic inter-
action between low level of chaperones and some null
mutation(s).
On the other hand, we agree that the case of a thermosensitive
mutation in a phage coat protein provides the currently best
example of chaperone-mediated buffering of mutational dam-
age. We were not familiar with this example because, as far as
we know, it was not mentioned in the literature on phenotypic
masking, genetic buffering, evolutionary capacitance, etc. We
now cite this work. However, we find it difficult to acknowledge
that the question of costs impaired by overexpression of chaper-
ones is less important than the fact that overexpression may
bring about phenotypic buffering (under laboratory condi-
tions). The balance between benefits and costs is the critical fac-
tor in evolution, especially in large natural populations.
We are not aware of previous articles that have called for recon-
sideration of the evolutionary role of molecular chaperones due
to their participation in protein quality control. This function is
by far less known than the role of chaperones in stabilization of
proteins and genetic networks, at least among evolutionary biol-
ogists and geneticists. Our message is not, or not only, that the
buffering effect of chaperone activity is rarer than believed. We
suggest that the scarcity of such evidence may have a deep func-
tional basis, that is, the dual role of chaperones as both helpers
and examiners of proteins.
We did mention that translational errors could be a source of
misfolded proteins, although very briefly. We now introduce the
requested citations and quantitative estimations of the rate at
which errors occur. Generally, we make clear that translational
errors together with macromolecular overcrowding are likely to
be a major source of misfolding of proteins coded by non-
mutated genes.
We did not suggest that anybody claimed that chaperones exist
in order to buffer genetic variation. It is generally agreed that
this can only be a secondary function. The question is whether
this is only a side effect or a factor in their evolution. The latter
would mean that the activity of chaperones is tuned in a way
that secures not only their standard functions but also allows for
accumulation of genetic variation. We now expand more on
this hypothesis by referring to the concept of Hsp90 as a 'general
regulator of evolvability'. This argument states that even if the
populations (lineages) with increased accumulation of buffered
mutations would be less fit over short time scales, they would
eventually win because of their supremacy during periods of
rapid adaptation. This idea is considered by many as controver-
sial and we add one more argument against it. The danger of
misfolding and aggregation of proteins coded by non-mutated
genes is probably high enough that lowering the stringency of
protein quality control in order to save rare mutants is unlikely.
These evolutionary questions, and not a critique of previous
experimental work, are the focus of our article. To make it obvi-
ous we rewrote the abstract and introduced several other clari-
fications.
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